AIDS

In Focus: Global strategy to end cryptococcal meningitis in people living with HIV

Cryptococcal meningitis is the second biggest killer of people living with HIV after tuberculosis (TB). Now, a global initiative, the Ending Cryptococcal Meningitis Deaths by 2030 Strategic Framework aims to get the gold standard drug to treat the disease – flucytosine – registered in countries that need it. By Amy Green for Spotlight and Health-e News.
Read More » In Focus: Global strategy to end cryptococcal meningitis in people living with HIV

Newsletter Subscription